Pulmonary Adenocarcinoma Updates: Histology, Cytology, and Grading.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 39667395.
- Also identified by DOI 10.5858/arpa.2023-0540-RA.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Adenocarcinomas are the most common histologic subtype of lung cancer, and exist within a widely divergent clinical, radiologic, molecular, and histologic spectrum. There is a strong association between histologic patterns and prognosis that served as the basis for a recently described grading system. As the study of molecular pathology rapidly evolves, all targetable mutations so far have been found in adenocarcinomas, thus requiring accurate diagnosis and classification for the triage of molecular alterations and adequate therapy. To discuss the rationale for adenocarcinoma classifications within the 2021 5th edition of the World Health Organization Classification, with a focus on nonmucinous tumors, including tumor grading and biopsy/cytology diagnosis. PubMed search. A grading system for adenocarcinoma has improved prognostic impact of the classification of pulmonary adenocarcinoma. An accurate diagnosis of adenocarcinoma in small biopsy material is important for tissue triage for molecular studies and ultimately for patient management and treatment.
Medical subject headings
- Lung Neoplasms
- Adenocarcinoma of Lung
- Adenocarcinoma